Atlas Trials

Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults

Clinical trial NCT04494373 · UNKNOWN

Trial details

NCT number
NCT04494373
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Bone Metastasis From Solid Tumors
Start date
2020-09-01
Primary completion
2021-06-30
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.